How long does one box of Mobosetinib/Mobosetinib last?

Mobocertinib is a targeted drug used to treat specific types of non-small cell lung cancer. Its common dosage form is 40 mg capsules, usually sold in a box of 112 capsules. The recommended dosage for adult patients is 160 mg per day, which means patients need to take four 40 mg capsules per day.

In this case, based on the recommended daily dose, a box of 112 tablets of moboxetinib can be used for approximately 28 days. This is calculated based on the daily dosage of 4 pills, so one box can meet the patient's medication needs for nearly a month. In actual clinical applications, patients will decide the duration of medication based on the doctor's prescription and specific circumstances. If a patient experiences disease progression or unacceptable toxicity, it may affect the planning and continuation of medication.

The use of mobosetinib is not simply a time calculation. Patients need to undergo regular medical evaluation during the medication process to monitor the efficacy and side effects. Due to individual differences in each patient, including severity of illness, tolerance and other medical conditions, the physician may adjust the dosage or change the treatment regimen based on the patient's specific response and tolerance. Although the recommended initial dose is 160 mg, in some cases, doctors may increase or decrease it appropriately based on the patient's actual condition.

In addition, patients need to pay attention to monitor possible side effects while taking moboxetinib. Common side effects include rash, diarrhea, fatigue, and mouth sores. These side effects may affect the patient's medication experience, so during use, patients should maintain communication with their doctor and report any discomfort in a timely manner. If side effects are intolerable, doctors may consider temporarily discontinuing the medication or changing the dose to ensure patient safety and therapeutic effectiveness.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1a91500-a944-4cb8-b4a8-ae278bcf728d##